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Abstract 
This paper reports on the findings of a study to derive a preference-based measure of health 
from the SF-36 for use in economic evaluation.  The SF-36 was revised into a six dimensional 
health state classification called the SF-6D.  A sample of 249 states defined by the SF-6D 
have been valued by a representative sample of 611 members of the UK general population, 
using standard gamble. Models are estimated for predicting health state valuations for all 
18,000 states defined by the SF-6D.  The econometric modelling had to cope with the 
hierarchical nature of the data and its skewed distribution. The recommended models have 
produced significant coefficients for levels of the SF-6D, which are robust across model 
specification. However, there are concerns with some inconsistent estimates and over 
prediction of the value of the poorest health states. These problems must be weighed against 
the rich descriptive ability of the SF-6D, and the potential application of these models to 
existing and future SF-36 data set.  
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1. Introduction  
Measures of health related quality of life (HRQoL) have become widely used by clinical 
researchers and can provide useful descriptive information on the effectiveness of health care 
interventions covering such disparate range of outcomes for HRQoL. However, these 
measures have not been designed for use in economic evaluation. The main shortcoming of 
using such instruments in economic evaluation is that they do not explicitly incorporate 
preferences into their scoring algorithms. 
This paper reports on a study to derive a preference-based measure of health from the SF-36, 
which is one of the most widely used generic measures of HRQoL in clinical trials.  It has the 
potential to considerably extend the scope for undertaking economic evaluation in health care 
using existing and future SF-36 data sets.   The paper also seeks to address the 
methodological issues this research task raises.    
The next section of this paper briefly describes the SF-36 and some of the problems of using 
it in its current form in economic evaluation. This is followed by a section describing the 
methods of the study, including: the rationale for the choice of approach, the changes made to 
the SF-36, the valuation survey using a version of standard gamble and the issues around 
modelling the data. The valuation survey is reported in sections four and five and the 
modelling reported in section six.  These types of stated preference data are complex to model 
due to their hierarchical nature and skewed distribution, and section six outlines alternative 
specifications for dealing with these problems. The final section considers how the results 
from this work can be used. 
 
2. The Short Form-36 (SF-36) Health Survey 
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The SF-36 health survey is a standardised questionnaire used to assess patient health across 
eight dimensions (Ware et al, 1993). It consists of items or questions which present 
respondents with choices about their perception of their health. The physical functioning 
dimension, for example, has 10 items to which the patient can make one of three responses: 
‘limited a lot’, ‘limited a little’ or ‘not limited at all’. These responses are coded 1, 2 and 3 
respectively and the ten coded responses summed to produce a score from 10 to 30. These 
raw dimension scores are transformed onto a 0 to 100 scale, which are not comparable across 
dimensions.  
There is extensive evidence of the ability of these scores to describe the health differences 
between different patient groups and more importantly for evaluation, their ability to detect 
health changes in populations following intervention (Garratt et al, 1993). However, the 
method of scoring the SF-36 is not based on preferences. The simple scoring algorithm it uses 
assumes equal intervals between the response choices (e.g. the change from ‘no limitation’ to 
‘limited a little’ is regarded as the same the change from ‘limited a little’ to ‘limited a lot’). 
Furthermore, it assumes the items are of equal importance; for example, being limited in 
walking has the same importance as being limited in climbing flights of stairs. The evidence 
has confirmed these concerns with the scoring. Studies have found only low to moderate 
correlations between HRQoL measures and preference-based measures (Revicki and Kaplan, 
1993). The absence of preference data makes it impossible to undertake any trade-offs 
between SF-36 dimensions, or between its dimensions and survival and/or cost.  
 
The remainder of this paper describes a study that introduces preferences into the scoring of 
the descriptive data in order to generate the health state utility values needed to construct 
QALYs and hence conduct cost-utility analyses.  
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3. Methods 
There are three components to this study. Firstly, the SF-36 has been reduced in size and 
complexity in order that respondents can process the information and hence give reliable 
valuations of health states. Secondly, a preference based valuation survey has been 
undertaken. Thirdly, the results of the survey were used in a model to predict values for all 
states of health described by the reduced form version of the SF-36, via alternative 
econometric techniques.  
Econometric methods to estimate a model to predict health state values was chosen over 
techniques based on multi-attribute utility (MAU) theory, such as used to value the HUI 
(Torrance, 1996), due to the structure of the SF-6D system.  The dimensions of the SF-6D are 
not strictly independent, so for example a health state with one dimensions at its worse level 
and all the other being at the best level is extremely unlikely to occur in practice and would 
not be credible with respondents. This presents problems in using MAU theory since it 
becomes necessary to back-off from these ‘corner state’.  Econometric methods do not rely on 
such corner states.   
The feasibility of this approach was demonstrated in a pilot survey. A specially derived 
reduced version of the SF-36 (the ‘SF-6D’) was valued by a convenience sample (n=165) 
using standard gamble (SG), and the results were modelled to estimate a scoring algorithm for 
deriving a preference based single index from the SF-36 (Brazier et al, 1998). This pilot study 
was constrained by the unrepresentativeness of the sample of respondents and limitations in 
the modelling owing to the small size of the dataset. Therefore the study reported in this paper 
was designed using a much larger representative sample of the UK population.  
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3.1 Deriving the SF-6D Health State Classification 
The SF-36 has 35 multi-level items used in its current scoring system, many of which have no 
obvious ordinal relationship; hence many millions of health states can be defined from this 
classification. The valuation of such a large multi-attribute function would present enormous 
estimation problems. Furthermore, experience from other research in transport and health, 
suggests that individuals can only process between five and nine pieces of information at a 
time (Miller, 1956; Pearmain et al, 1991; Dolan et al, 1995). The aim of this stage of the 
project was to produce a health state classification which was amenable to valuation by 
respondents subject to the constraint that responses to the SF-36 could be unambiguously 
mapped onto it.  
The main task was to substantially reduce the number of items for the health state 
classification. The principle criterion was to minimise the loss of descriptive information. 
This item selection process was able to benefit from the research undertaken by Dr John Ware 
and his colleagues on the descriptive importance of the items of the SF-36 in terms of their 
overall contribution to longer versions of the dimension scores (Ware et al, 1995). They 
undertook extensive factor analyses to determine the relative contribution of items to their 
overall dimension scores. This work has already contributed to a further shortened version of 
the instrument, the SF-12, which has become widely used in the USA.  
 
3.2 The SF-6D health state classification 
The number of dimensions was reduced from eight to six. This was achieved firstly, by 
excluding all general health items since the purpose is to generate a single index for health 
brazierje10.doc 4
 5
and it would be illogical to include a general health dimension as a constituent element. 
Secondly, the dimension ‘role limitation due to physical problems’ was combined with ‘role 
limitations due to emotional problems’ to form a single dimension for simplicity.  However, 
this important distinction between different sources of role limitation is not lost in the derived 
health state classification system.  
 
The final selection of items uses 8 from the SF-12 and three other items from the SF-36 
physical functioning dimension to extend the scale to cover the full range of functioning 
problems. The result is a six dimensional health state classification shown in Table 1, which 
has been called the SF-6D.  The SF-36 items used in the SF-6D are listed at the bottom of the 
table. This version of the SF-6D differs in a number of important respects from the pilot 
version published in Brazier et al, (1998). 
The SF-6D has six dimensions (δ = 1,2,…,6), each with between two and six levels (λ). An 
SF-6D health state is defined by selecting one statement from each dimension, starting with 
physical functioning and ending with vitality (see Table 2 for examples). A total of 18000 
health states can be defined in this way. All responders to the original SF-36 questionnaire 
can be assigned to the SF-6D provided the 10 items used in the six dimensions of the SF-6D 
have been completed.  
 
4. The valuation survey 
The basic design of the survey was that a sample of 249 health states defined by the SF-6D 
was valued by a representative sample of the general public (n = 836). Each respondent was 
asked to rank, and then value, six of these states using a variant of the SG technique. 
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4.1 Selection of respondents 
A representative sample of the general population should be used in this survey since the 
purpose is to inform the allocation of public resources (Gold et al, 1996). The aim of the 
sampling has been to ensure the sample should reflect the variability of the population in 
terms of characteristics such as age, socio-economic status and level of education. The sample 
was drawn using a two-stage cluster random selection design. The primary units were 
postcode sectors stratified by percentage of households with a non-manual occupation. Fifty 
one postcode sectors were selected, and addresses randomly selected from each of these, 
resulting in 1445 potential interviews. Where more than one adult (i.e. 16 or over) was found 
in household, one was selected at random by the interviewer using a standard Kish selection 
grid.  
 
4.2 Selection of health states 
For such a large descriptive system, where it is not possible to value all possible combinations 
of each dimension or attribute, there is little guidance in the statistics literature on selecting 
samples for valuation. The minimum sample of health states was identified using an 
orthogonal design (by applying the Orthoplan procedure of SPSS), which generated 49 health 
states (out of 18,000) required in order to estimate an additive model. It was anticipated that 
more complex specifications, allowing for some form of interaction between dimensions, 
would be estimated and therefore it was desirable to value more states. Another reason for 
valuing more states was to provide scope for examining the predictive ability of the models 
subsequently estimated. However, resources constrained the survey to around 800 interviews. 
The choice was therefore to maximise the number of valuations per state (hence choose the 
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minimum number of states, 49), or maximise the number of health states valued or some 
combination of the two. The latter course was chosen. States were classified as mild, 
moderate or severe and a stratified sampling method was used to supplement the 49 states 
selected by Orthoplan with a further 200 states, to provide 249 health states for valuation. 
Each respondent was asked to value six health states. Care was taken to ensure each person 
was asked to value a range of health states across the space defined by the SF-6D rather than 
a predominantly ‘good’ or ‘bad’ selection of states (Brazier et al, 1999b). The allocation 
procedure was also designed to maximise the chance that each of the 249 cards would be 
valued by an equal number of respondents.  
4.3 The interviews 
A trained and experienced interviewer conducted the interviews in the respondent’s own 
home. The interviewers were employed by the Social and Community Planning Research 
(SCPR), who are a private survey organisation that has undertaken numerous surveys for 
Government agencies and academics, including the MVH EQ-5D valuation survey (Dolan et 
al, 1995). The interview began with the respondent being asked to complete a short self-
completion questionnaire about his or her own state of health, that included completing the 
SF-6D in the format that appears in Table1. This familiarised the respondent with the idea of 
describing health in terms of the SF-6D. It also provides a self-assessment of health which 
could be subsequently used in the modelling to estimate the impact of respondent’s own 
health on their valuation of other health states.  
At the next stage of the interview, the respondent was asked to rank a set of eight cards: one 
for each of the health states they would have to value, along with the best state defined by the 
SF-6D, the worst state and immediate death. This task provided an opportunity for the 
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respondent to familiarise themselves with the cards and the notion of having preferences for 
one health state over another.  
The main part of the interview was the SG valuation of six health states.  This study 
employed a variant of the SG using props developed by a team at McMaster  (Furlong et al, 
1990).   In the interview, the respondent is asked to choose between the certain prospect (A) 
of living in an intermediate state defined by the SF-6D and the uncertain prospect (B) of two 
possible outcomes, the best state defined by the SF-6D or the worst (‘pits’). The chances of 
the best outcome occurring is varied until the respondent is indifferent between the certain 
and uncertain prospects.  At all times the probabilities are displayed on a chance board, both 
numerically and in the form of a pie chart. This ‘ping pong’ with props version of SG was 
chosen for its ease of use by interviewers. The chance board is designed to make the interview 
as straightforward as possible, by leading the interviewer through a set of questions 
depending on the respondents answer to the previous question, and minimise the risk of 
interviewer variation. The developers have tried and tested the procedure and its associated 
prop over many years and it has become widely used in health economics. The McMaster 
team were able to provide training to the study investigators and produce the chance boards 
for the survey interviewers. All interviewers were trained in the use of this SG valuation 
technique by the investigators.  
In the SG valuation task respondents were asked to value each of the five certain SF-6D 
health states against the best and ‘pits’ health state. For calculating QALYs it is necessary to 
transform the results onto a scale where 1 is full health and 0 equivalent to death. The best 
health state defined by the SF-6D is full health.  The worst state defined by the SF-6D must 
be valued on the full health to death scale and the five health state values adjusted 
accordingly. All respondents were therefore asked a sixth SG question. Depending on 
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whether they thought the ‘pits’ state was better or worse than death they would be asked to 
consider a choice between either: i) the certain prospect of being in the ‘pits’ state and the 
uncertain prospect of full health (state 111111) or immediate death, or ii) the certain prospect 
of death and the uncertain prospect of full health or the ‘pits’ state.  
The use of the ‘pits’ state as the reference state is an important feature of the SG valuation 
task used in the survey. It is more conventional to use death as the worst outcome (and more 
convenient for the purposes of deriving QALYs where it is necessary to place the health state 
values directly onto a scale where 1 is full health and 0 is regarded as equivalent to death). 
The ‘pits’ state was chosen for two reasons. The first arose from a concern that the ‘ping 
pong’ version of SG used in the survey was insensitive at the upper end of the scale. 
Respondents are asked to consider probabilities up to 0.95 and yet the pilot study using an 
earlier version of the SF-6D found many respondents would only consider having the 
operation at higher odds (Brazier et al, 1998). The two stage valuation process allows 
respondents who believe the ‘pits’ state is better than death (and most did) to value the 
intermediate state above 0.975. The second benefit is that it enables people who regard the 
‘pits’ state and other health states defined by the SF-6D to be worse than death to do so in one 
go at the end of the interview rather have to incorporate the states worse than death gamble 
into every question.  
It was necessary to ‘chain’ the health state values in order to place them on the zero to one 
scale. For health states better than death, where the best outcome is set at 1 and death is 0, 
then expected utility theory would indicate that the health state value of the intermediate state 
is the probability of the better outcome at the respondent’s point of indifference. For states 
worse than death, the equivalent value would be -P/(1-P); where P is the valuation of the 
‘pits’ state. However, this results in a scale ranging from -∞ to +1, which gives greater weight 
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to negative values in the calculation of mean scores and presents problems for the statistical 
analysis. It has therefore been recommended in the literature that states valued worse than 
death should be simply the negative of the indifference probability of the best outcome 
(Patrick et al, 1994). This has the effect of bounding negative values at minus one.  It is 
acknowledged that this has no theoretical support and is only one of a number of possible 
ways of dealing with the problem, but it is one that has become widely used elsewhere in the 
literature and a similar transformation has been used on TTO values in the MVH study 
(Dolan, 1997).  Furthermore, it is less of an issue in the valuation of the SF-6D since there are 
proportionately fewer SG observations below zero and very few below minus one using the 
formula -P/(1-P) than has been found for the HUI and EQ-5D.   
Having valued the ‘pits’ state (P), the final step is to adjust the five intermediate SF-6D health 
state valuations (SG) onto the scale where the best SF-6D state is 1 and death 0. The health 
state value used in the modelling is therefore: SGADJ = SG + (1-SG) * P.          
 
5. The Data  
Out of the 1445 addresses contacted for interview, 167 proved to be ineligible1. Of the usable 
addresses there were 836 successfully conducted interviews (a 65% response rate). 
Respondents were found to be representative of the national population in terms of the 
distribution by age group, education and social class (Sturgis and Thomas, 1998).  
One hundred and thirty respondents had to be excluded from the analysis for failing to value 
the ‘pits’ state; therefore it was not possible to generate an adjusted SG value (see below). A 
further 9 were excluded for not valuing two or more health states. Finally, there were 86 
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respondents whose health state values did not change between the five states. This last group 
have been excluded because the lack of variation is likely to indicate that the respondent did 
not understand the task. Other grounds for excluding individuals were considered, such as 
logical inconsistencies between their responses and the ordinal properties of the SF-6D, but 
these were discounted in favour of leaving individuals in the data set where possible. 
A comparison of included and excluded respondents is presented in Table 3. The 225 
excluded cases tended to be older, were marginally more likely to be male and unmarried, and 
less likely to have children under 16. They were more likely to rent rather than own their 
home and were less likely to be in full-time employment. They tend to have less educational 
qualifications and were slightly more likely to have problems understanding the standard 
gamble valuation task. Out of the 611 individuals included in the data set there were 148 
missing values from 117 individuals. This results in 3518 observed SG valuations across 249 
health states and these form the data set reported and analysed below.  
 
5.1 Health state values 
Descriptive statistics for 50 of the 249 health states are shown in Table 4. Each health state 
has been valued an average of 15 times. Mean health state values range from 0.10 to 0.99, and 
generally have large standard deviations. Median health state values usually exceed mean 
values, reflecting the positive skewness of the data. The relative health state valuations 
broadly conform with the logical ordering of the SF-6D. 
                                                                                                                                                        
1  These were addresses which contained no resident household for various reasons including: insufficient 
address, not traced, not yet built, derelict/demolished, business only, empty, institution only, 
weekend/holiday home. 
brazierje10.doc 11
 12
At the level of individual observations the degree of skewness is even more evident. A 
histogram and descriptive statistics for the 3518 individual adjusted health state valuations is 
shown in Figure 1. Negative observations did occur but were comparatively rare (245/3518) 
and over 23% of observations lie between 0.9 and 1.0. Interestingly, even for the ‘pits’ health 
state most respondents valued it as better than death (445/611). However, very few health 
states were valued at 1.0 (20/3518), indicating the willingness of respondents to risk a worse 
health state in order to have the chance of a better state of health.  
 
6. Modelling 
The overall aim is to construct a model for predicting health state valuations based on the SF-
6D. The appropriate modelling strategy is not clear a priori, and the econometric analysis is 
necessarily of an exploratory nature (Busschbach et al, 1999). The data generated by the 
valuation survey described above, has a complex structure which creates a number of 
problems for econometric estimation. Firstly, the data are skewed and bimodal (see Figure 1). 
Conventional power transformations are therefore not appropriate. The skewness in the data 
also raises questions about the appropriate measure of central tendency. There are statistical 
and political (e.g. median voter) arguments for using the median, but for economic evaluation 
the mean is usually recommended. The choice of dependent variable in this respect is also 
influenced by the second consideration - the form of heterogeneity that characterises this data.  
Variation is both between respondent and within respondent (across health states). 
Furthermore, health state valuations are likely to be clustered by respondent. Level 1 denotes 
the individual health state valuations, which are clustered according to level 2 – the 
respondents. Respondents did not value the same set of states, although allocation of states to 
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respondents was essentially random, differences between health state values may be partly 
due to differences in the preferences of the respondents, rather than the attributes of those 
states. Disentangling the respondent effect is a complex task and can only be tackled at the 
individual level, where each valuation is regarded as a separate observation, rather than using 
the mean value for each health state. The former has the advantage of greatly increasing the 
number of degrees of freedom available for the analysis (from 249 to over 3500) and enabling 
the analysis of respondent background characteristics on health state valuations. Despite these 
apparent advantages, it is not clear whether one is necessarily superior for the purposes of 
predicting mean health state values (Gravelle, 1995) and hence models have been estimated at 
both the individual and aggregate levels.  
 
6.1 Models 
A number of alternative models can be formulated for predicting the SG gamble scores 
generated in the valuation survey. The general model is defined as:  
ijjijijij gy εδθβ +′+′+′= )( zrx    (1) 
where i = 1, 2, …, n represents individual health state values and j = 1,2, …, m represents 
respondents. The dependent variable, yij, is the adjusted SG score for health state i valued by 
respondent j (SGADJ). x is a vector of dummy explanatory variables (xδλ) for each level λ of 
dimension δ of the SF-6D. For example, x31 denotes dimension δ = 3 (social functioning), 
level λ = 1 (health limits social activities none of the time). For any given health state, xδλ 
will be defined as  
xδλ = 1 if, for this state, dimension δ is at level λ 
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xδλ = 0 if, for this state, dimension δ is not at level λ 
In all there are 25 of these terms, with level λ = 1 acting as a baseline for each dimension. 
Hence for a simple linear model, the intercept represents state 111111, and summing the 
coefficients of the ‘on’ dummies derives the value of all other states.  
The r term is a vector of terms to account for interactions between the levels of different 
attributes. The estimation of all possible interaction terms would have required a substantially 
larger proportion of the 18,000 health states of the SF-6D to be valued. There are, for 
example, 465 first order interactions alone. Given, the large number of possible interactions, 
and little evidence on which are likely to be important, there is a risk of finding significant 
interactions due to the play of chance. Further discussion of interaction effects is given below. 
z is a vector of personal characteristics that may also affect the value an individual gives to a 
health state, for example, age, sex and education. The role of personal characteristics is not 
discussed in this paper. g is a function specifying the appropriate functional form. εij is an 
error term whose autocorrelation structure and distributional properties depend on the 
assumptions underlying the particular model used.  
This is an additive model, which, apart from additivity, imposes no restrictions on the 
relationship between dimension levels of the SF-6D. For example, it does not enforce an 
interval scale between the levels of each dimension. Earlier empirical work on valuing the 
Euroqol assumed equal intervals, but this has since been found to be invalid for certain 
dimensions (van Hout and McDonnell, 1991, and Dolan, 1997). This additive model does not 
impose ordinality on the levels.  
 
6.2 Alternative Model Specifications 
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The starting point is OLS estimation of model (1), with g as a linear function. This simple 
specification assumes a standard zero mean, constant variance error structure, with 
independent error terms, that is cov(εij,εi'j) = 0, i≠i'. This specification ignores the potential 
multilevel variation in the data and assumes that each individual health state value is an 
independent observation, regardless of whether or not it was valued by the same respondent.  
An improved specification, which takes account of variation both within and between 
respondents, is the one-way error components random effects model. This model explicitly 
recognises that n observations on m individuals is not the same as n×m observations on 
different individuals. For the random effects model the errors from model (1) are subdivided 
such that, 
    ijjij eu +=ε      (2) 
uj is respondent specific variation, which is assumed to be random across individual 
respondents. eij is an error term for the ith health state valuation of the jth individual, and this is 
assumed to be random across observations, with eij ~ [0, ]. In addition cov(uj,eij) = 0 which 
signifies that allocation of health states to respondents is random. Estimation is via 
generalised least squares (GLS) or maximum likelihood (MLE).  
2
eσ
A one-way error components fixed effects model can also be specified. This differs from the 
random effects specification in that the respondent specific effects uj are not assumed to be 
random, but are a set of fixed effects to be estimated, together with the vector of coefficients 
on the explanatory variables; hence cov(ujxij) ≠ 0.  
The choice between random and fixed effects specification depends largely on the sample 
design and the purpose of the study. In this case, respondents constitute a random sample and 
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the assumption of the random effects specification are met. Ultimately the choice is an 
empirical matter and will be determined by the Hausman test.  
The multi-level nature of variation in these data suggests a further class of models for 
consideration, those developed specifically to deal with hierarchical data structures. The two-
level multi-level model is similar to the one-way error components random effects model, and 
algebraically can be denoted by the specification given in (1) and (2) above. Estimation is by 
iterative GLS (IGLS), and this allows for more complex modelling of the variance 
components observed at both levels of the hierarchy (Goldstein, 1995).  
Finally we consider alternative functional forms - g in (1) - to account for the skewed 
distribution of health state valuations. Four functional forms are used. Firstly, a Logit 
transformation and two complementary log-log transformations suggested by Abdalla and 
Russell (1995). These are chosen to map the data from the range (-1,1) to the range (-∞,∞) via 
the unit range (0,1).  
Before applying these transformations it was necessary to transform the SGADJ data to get 
rid of negative values using:  
  SGADJU=(SGADJ+1)/2     (3) 
Secondly, a Tobit transformation which, although designed to deal with truncated data, can 
approximate for the left skew in this data, where 25% of the values lie between 0.9 and 1. 
This is done by specifying a Tobit model with upper censoring at 1.  
All modelling was done using EVIEWS 3.1, STATA 6.0 and MLwinN 1.02. 
 
6.3 Interaction Effects 
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Analysis of first order interaction effects was problematic, since the large number of possible 
effects means there is a risk of finding some are significant purely by chance. Also when first 
order interaction terms were found to be significant, they generally displaced the main effects 
due to collinearity between main effects and first order interaction terms.  
It was therefore necessary to investigate alternative ways of accounting for interactions. 
Extreme level dummies were created to represent the number of times a health state contains 
dimensions at the extreme ends of the scale (Dolan, 1997). Least severe is defined as level 1 
or 2 on each dimension. Most severe is defined as levels 4 to 6 for physical functioning (PF), 
levels 3 and 4 for role limitation (RL), 4 and 5 for social functioning (SF), mental health 
(MH) and vitality (VIT), and 5 and 6 for pain. A number of alternative definitions of most and 
least severe were investigated but these made little difference to the results. The most and 
least extreme dummies are denoted by EMδ and ELδ respectively, where δ = 1,2,…,6 and 
describes the number of times the least or most severe levels appear in a state.  
Two further methods for accounting for any additional effect from dimensions at the most 
severe levels were tried. Firstly, count variables represent the number of dimensions at the 
least (most) severe level. Secondly, dummy variables LEAST (MOST) take a value of 1 if 
any dimension in the health state is at the least (most) severe level, and 0 otherwise. Further 
dummies MOSTn (n = 2, 3, …,5) takes the value 1 if at least n dimensions are at the most 
severe level.  
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Functional Form 
Four transformations have been attempted to get remove the skew in the health state valuation 
data. Three ad hoc adjustments suggested by Abdalla and Russell (1995)2 and a TOBIT 
transformation. All of these transformations were modelled with random effects since 
Breusch Pagan and Hausman tests suggest these are appropriate.  
(i) Logit transformation,   SGAG1 = ln (SGADJU /(1 – SGADJU) 
(ii) complementary log-log transformation SGAG2 = ln (-ln (1 – SGADJU) 
(iii) complementary log-log transformation SGAG3 = ln (- ln (SGADJU) 
(iv) Tobit transformation (see Breen, 1996). 
6.4 Results 
Basic Models – Main Effects  
The results are shown in Table 5 for OLS and random effects models at the individual level, 
and OLS models using mean and median health state values. These models include only the 
main effects dummies. 
The main effects dummies represent progressively worse problems on each dimension 
compared to a base line of no problem for that particular dimension. As such the coefficient 
estimates are expected to be negative and increasing in absolute size. An inconsistent result 
occurs where a coefficient on the main effects dummies decreases in absolute size with a 
worse level. 
                                                 
2  Abdalla and Russell (1995) did not attempt to model transformed data while also allowing for individual 
effects. Here we attempt to simultaneously cope with these two characteristics of the data.  
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For the OLS model (1) the vast majority of coefficients have the expected (negative) sign. In 
all 13 of the 26 coefficients are significant and there are 2 inconsistencies, where the 
estimated effect decreases from RL3 to RL4, and VIT2 to VIT3. The explanatory power of 
the model is 0.204. Diagnostic tests reveal problems with non-normal and heteroscedastic 
residuals3. Further these data represent repeated observations on 611 individuals and a 
Breusch-Pagan LM test for individual effects reveals that these are important (χ2 = 1717.02, p 
= 0.000). In addition Hausman’s test suggests that random, rather than fixed, effects, is the 
appropriate specification ((χ2 = 27.11, p = 0.35)4.  
For the random effects specification all coefficients have the expected negative sign. There 
are 17 significant coefficient estimates and 2 inconsistencies, with a decrease in the size of the 
coefficient from PF4 to PF5 and SF2 to SF3. Explanatory power is 0.200 and the variance 
decomposition suggests slightly more variation between respondents than within respondents. 
The Breusch–Pagan test for heteroscedasticity suggests that a problem still exists. The 
Ramsey RESET test shows no evidence of specification problems which is surprising given 
the skewness of the residuals.  
The mean (3) and median (4) models presented in Table 5 have much greater explanatory 
power than the individual level models, explaining almost 60% of the variation in health state 
values. The mean model has serial correlation and heteroscedasticity problems, while the 
median model appears to have non-normal residuals.  
Coefficients can be compared directly across the first 4 models presented in Table 5. There 
are similarities in that the important effects are found among the most severe levels of each 
dimension. Most of these effects are robust across model specification. 
                                                 
3  The model was estimated using White’s heteroscedasticity consistent standard errors.  
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Predictive Ability 
Given our overall aim of predicting health state valuations the best way to compare these 
models is via their predictive ability. Summary statistics for inside sample predictions are 
presented in the lower half of Table 5. The median model appears to be the worst but there is 
little to chose between the other three, which have similar mean absolute errors (MAE) and 
result in similar numbers of errors greater than 0.05 and 0.10 in absolute value. The 
proportion correctly predicted to within |0.1| was nearly 80%, and 54% to within |0.05|. In all 
cases the predictions are unbiased (t-test), and prediction errors are normally distributed (JB 
test).  
The most serious problem at this stage is that Ljung-Box (LB) statistics reveal significant 
autocorrelation in the prediction errors of all models, when the errors are ordered by actual 
mean health state valuation. Figure 2 shows actual and predicted health state valuations for 
the random effects model (2). This reveals a tendency to over predict at low health state 
values (i.e. poor health states) and under predict at high health state values. A similar result is 
found for all models (1) to (4).  
Restricting the intercept to unity 
There are strong theoretical arguments for restricting the intercept to unity. The adjusted SG 
value for each state has been estimated according to the axioms of EUT by assuming SF-6D 
state 111111 health is to equal one and death is equal to zero.   For state 111111 to hold any 
other value would change the scale.  Furthermore, for use in CUA it is necessary to assume 
                                                                                                                                                        
4  Hierarchical models were estimated using MLwiN 1.02. The results are identical to those for the random 
effects models to 4 decimal places.   
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that health state 111111 is equivalent to full health and hence has a value of one.  The best 
way to ensure health state 111111 has a value of one is to restrict the intercept to unity.  
For models (5) and (6) in Table 5 the intercept has been restricted to unity. Coefficient  
estimates can be directly compared to those for models (1) to (4). For both of these models 
there is a substantial increase in the number of significant coefficient estimates and a slight 
increase in the number of inconsistencies. While there is a slight increase in error size 
compared with models (2) and (3) there is less autocorrelation in the errors; although the LB 
statistics are still significant. Figure 3 shows actual and predicted health state valuations for 
the random effects model (5). This shows that while the tendency to under predict at good 
health states has been removed there is still a problem of over prediction at poor health states. 
A similar result is found for the mean model.  
Interaction Effects 
Models which include some of the interaction effects discussed above are presented in Table 
6. A number of ways of dealing with interaction effects were investigated and these three 
models are the most successful. The random effects and mean models (7 and 8) include the 
dummy variables MOST and LEAST, which take a value of 1 if any dimension in the health 
state is at the most or least severe level. The coefficient estimates suggest a further negative 
effect if any dimension is at the most severe level which is slightly reduced by a positive 
effect of dimensions at the least severe level. The coefficients on the main effects dummies 
are slightly reduced as expected but are robust to the inclusion of the interaction effects.  
These models show little improvement in predictive ability above models (2) and (3).  
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Models (9) and (10) are the equivalent with the intercept forced to unity; here only the MOST 
dummy is significant at t0.05 . Again these results are very similar to those of models (5) and 
(6) with little or no improvement in predictive ability.  
The alternative functional forms do not perform well in terms of predictive ability. They all 
give biased predictions (t-test) and in general they result in larger errors than the 
untransformed models5.  
 
7. Discussion and conclusion 
The results of this study offer a method for analysing existing SF-36 data from trials and other 
sources of evidence where there is no other means of estimating the preference-based health 
values for generating QALYs.  It also provides an alternative to existing preference-based 
measures of health for use in cost utility analysis.  Two of the leading preference-based 
measures are the EQ-5D (Brooks, 1996) and the Health Utility Index (Torrance et al, 1995).  
Whether or not the SF-6D offers an improvement on these existing measures depends on 
one’s view of the appropriate definition of health, the valuation techniques and the best 
method for modelling health state values (Brazier et al, 1999). There is insufficient space in 
this paper to go into these issues.  However, one of the advantages of the SF-6D over the EQ-
5D could come from the much larger size of its descriptive system and hence a possibly 
greater degree of sensitivity.  This must be weighed against the inconsistencies between the 
coefficients at the upper levels of some SF-6D dimensions.  The sensitivity of the new index 
needs to be compared to other preference-basecd measures before drawing any conclusion on 
this point. Any greater sensitivity would be most likely in groups experiencing mild to 
                                                 
5 Predicted values have been retransformed using the smearing estimator (Rutten-van Mölken et al, 1994) 
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moderate health problems and in those expected to experience comparatively small changes 
or where small differences are expected between interventions.  
An important question is whether the derivation of the SF-6D health state classification has 
compromised the descriptive richness and sensitivity of the original SF-36. The selection of 
items was intended to minimise the potential loss of information but the loss may offset the 
advantages of the SF-36.  This is an empirical question to be addressed in future research.  
The models have produced significant coefficients for levels of the SF-6D with the expected 
negative sign. These main effects are robust across model specification and in most cases they 
are consistent with ordinal levels of the SF-6D. However, there are concerns with the 
individual level models low explanatory power.  At the individual level explanatory power 
reached 0.2 compared with 0.45 for the York MVH models for the EQ-5D (Dolan, 1997). The 
size of the mean absolute error was correspondingly smaller.  Comparisons between these two 
pieces of work is difficult since the valuation of the SF-6D is much larger undertaking 
describing nearly 75 times more states.  More relevant for CUA is the ability of the model to 
predict mean health state values and the best mean model achieved an adjusted R-squared of 
0.58. 
Another concern is the existence of inconsistencies between coefficients on the SF-6D levels. 
In many cases the estimated coefficients on lowest levels of each dimension are not 
statistically significant (e.g. the coefficients on PF2 and PF3 in the recommended model 10), 
hence the fact that PF3 attracts a point estimate lower than PF2 is not an inconsistency, since 
they are both interpreted as zero.  Therefore we interpret an inconsistency as only occurring 
between  significant coefficients and the number of these is quite low compared to the number 
of consistent coefficients.   Those inconsistencies that occur in more than one of the four 
models reported in Table 6 are as follows: PF4 vs PF5, RL3 vs RL4, VIT2 vs VIT3 and 
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PAIN2 vs PAIN 3. There is no clear ordinal relationship between PF4 and PF5 and hence this 
may not be an inconsistency at all.  RL3 vs RL4 have similar coefficients across all models 
and this indicates that most respondents did not distinguish between them.  For VIT2 vs VIT3 
one possible explanation is that this dimension is worded in the positive rather than the 
negative and this may have caused some confusion for respondents.  Finally, PAIN2 and 
PAIN3 are not significant in models (7) and (8) and similar in models (9).  In model (10) 
PAIN3 attracts an insignificant coefficient estimate, whereas PAIN2 is significant suggesting 
an inconsistency.  But like the remaining 3 inconsistencies it occurs only once across the four 
specifications.  We do not believe these inconsistencies have any serious implication for the 
performance of the model as whole except for a reduction in sensitivity at the upper end for 
some dimensions.  Of course, a larger sample size and the valuation of additional health state 
may have overcome some of these problems. 
Of more concern is the existence of systematic prediction errors resulting from all the models. 
Introducing interaction terms leads to little improvement in predictive ability and we still 
have a problem of under predicting the value of good health states and over predicting the 
value of poor states in the models with an estimated intercept terms. Restricting the intercept 
to unity eliminated the former problem, whilst the latter remains.  We have attempted 
numerous other alternative specifications for interactions not reported in this paper, but these 
did not produce significant results.  
A number of models have been presented for predicting preference-based health state values 
from SF-36 data.  Whilst we have shown the RE model to be better than OLS at the individual 
level, we do not believe the RE offers any clear advantages over the mean level models.  
Indeed, the mean model is marginally better across the different tests of fit.  Given the task is 
to predict mean health state values there is no reason to favour the individual level models 
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and therefore we recommend using one of the mean level models.  The interaction terms lead 
to very modest improvements in the model and should therefore be used. As argued earlier in 
this paper, we also favour restricting the intercept to unity for the purposes of generating 
models for use in CUA.  The preferred model for use in CUA is therefore (10) in Table 66.   
 
This paper has presented a study to estimate a preference-based single index from one of the 
larger generic profile measures of health related quality of life. It is only the second time this 
has been done, the first being essentially a pilot to this study (Brazier et al, 1998).  This 
research demonstrates that it is possible to estimate preference weights for measures of health 
related quality.  The paper presents the key methodological issues involved in undertaking 
such a task, including the derivation of a health state classification, the valuation survey and 
modelling.    The results can be applied to any SF-36 data set and hence considerably expand 
the available evidence base for conducting economic evaluation of health care interventions. 
                                                 
6 A computer algorithm for deriving a preference-based index from SF-36 data via the SF-6D is available from 
the corresponding author.  The algorithm is copyrighted, though it is free of charge for non-commercial uses. 
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Figure 1: Histogram and Descriptive Statistics for Adjusted Health State Valuations 
(SGADJ) 
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Figure 2:  Actual and Predicted Health State Valuations for the Random Effects Model 
(2) 
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Figure 3:  Actual and Predicted Health State Valuations for the Random Effects Model 
(5) 
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Table 1: The Short Form 6D 
 
Level Physical Functioning Level Pain 
1 Your health does not limit you in vigorous activities 1 You have no pain 
2 Your health limits you a little in vigorous activities 2 You have pain but it does not interfere with your normal work (both 
outside the home and housework) 
3 Your health limits you a little in moderate activities  3 You have pain that interferes with your normal work (both outside 
the home and housework) a little bit
4 Your health limits you a lot in moderate activities  4 You have pain that interferes with your normal work (both outside 
the home and housework) moderately
5 Your health limits you a little in bathing and dressing  5 You have pain that interferes with your normal work (both outside 
the home and housework) quite a bit
6 Your health limits you a lot in bathing and dressing 6 You have pain that interferes with your normal work (both outside 
the home and housework) extremely
 
 
 
Role limitations 
 
 
 
Mental health 
1 You have no problems with your work or other regular daily activities as a result 
of your physical health or any emotional problems 
1 You feel tense or downhearted and low none of the time
2 You are limited in the kind of work or other activities as a result of your physical 
health 
2 You feel tense or downhearted and low a little of the time
3 You accomplish less than you would like as a result of emotional problems 3 You feel tense or downhearted and low some of the time
4 You are limited in the kind of work or other activities as a result of your physical 
health and accomplish less than you would like as a result of emotional problems 
4 You feel tense or downhearted and low most of the time
  
 
Social functioning 
5 You feel tense or downhearted and low all of the time 
 
Vitality 
1 Your health limits your social activities none of the time 1 You have a lot of energy all of the time
2 Your health limits your social activities a little of the time 2 You have a lot of energy most of the time
3 Your health limits your social activities some of the time 3 You have a lot of energy some of the time
4 Your health limits your social activities most of the time 4 You have a lot of energy a little of the time
5 Your health limits your social activities all of the time 5 You have a lot of energy none of the time
 
Footnote: The SF-36 items used to construct the SF-6D are as follows: physical functioning items1, 2 and 10; role limitation due to physical problems item 3; 
role limitation due to emotional problems item 2; social functioning item 2; both bodily pain items; mental health items 1 (alternate version) and 4; and vitality 
item 2.  
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Table 2:  A sample of health states defined by the SF-6D 
 
Health state 111111 
 
Your health does not limit you in vigorous activities 
(e.g. running, lifting heavy objects, participating in 
strenuous sports). 
 
You have no problems with your work or other 
regular daily activities as a result of your physical 
health or any emotional problems. 
 
Your health limits your social activities (like 
visiting friends or close relatives) a little or none of 
the time 
 
You have no pain 
 
You feel tense or downhearted and low a little or 
none of the time. 
 
You have a lot of energy all of the time
 Health state  223222 
 
Your health limits you a little in vigorous activities 
(such as running, lifting heavy objects, participating 
in strenuous sport) 
 
You are limited in the kind of work or other activities 
as a result of your physical health  
 
Your health limits you in your social activities some 
of the times
 
You have pain but it does not interfere with your 
normal work (both work outside the home and 
housework)  
 
You feel tense or downhearted and low a little of 
the time. 
 
You have a lot of energy most of the time. 
 
 
   
Health state 424334 
 
Your health limits you a lot in moderate activities 
(such as moving a table, pushing a vaccum cleaner, 
bowling or playing golf) 
 
You are limited in the kind of work or other 
activities as a result of your physical health  
 
Your health limits you in your social activities most 
of the time 
 
You have pain that interferes with your normal work 
(both outside the home and housework) a little bit. 
 
You feel tense or downhearted and low some of 
the time. 
 
You have a lot of energy a little of the time.
 
 
 Health state 645655 (‘pits’) 
 
Your health limits you a lot in bathing and dressing 
yourself. 
 
You are limited in the kind of work or other activities 
as a result of your physical health and you 
accomplished less than you would like as a result of 
emotional problems  
 
Your health limits your social activities all of the 
time 
 
You have pain that interferes with your normal work 
(both outside the home and housework) extremely.
 
You feel tense or downhearted and low all of the 
time. 
 
You have a lot of energy none of the time. 
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Table 3: Characteristics of included and excluded respondents 
 Included Excluded 
 n = 611 n = 225 
Age: mean (s.d) 46 (18.1) 51 (19.6) 
%    
female 61 56 
married 53 48 
with children < 16 28 21 
renting property 28 34 
in FT employment  37 32 
Highest qualification 
 degree 
 
16 
 
13 
 A levels 21 18 
No qualifications 30 37 
   
Found valuation task difficult1  4 5 
Poor understanding of valuation task2 4 9 
1 judged by respondent 
2 judged by interviewer 
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Table 4: Descriptive Statistics for 50 SF-6D health state valuations 
state n Min Max Mean Median s.d. 
111111 13 0.92 1.00 0.99 1.00 0.02 
111215 13 0.53 1.00 0.90 0.97 0.14 
321221 11 0.57 0.98 0.84 0.89 0.13 
122233 15 0.14 1.00 0.83 0.91 0.23 
112221 11 0.51 0.98 0.82 0.89 0.17 
221432 10 0.53 0.98 0.81 0.84 0.15 
224223 14 0.53 1.00 0.80 0.85 0.17 
532124 12 0.29 1.00 0.79 0.84 0.21 
211111 12 0.19 1.00 0.78 0.90 0.27 
221211 10 0.42 0.98 0.77 0.85 0.19 
341123 11 0.10 0.99 0.76 0.92 0.31 
241531 17 0.28 0.99 0.75 0.88 0.24 
213323 13 0.12 0.98 0.74 0.79 0.25 
222113 17 0.10 0.99 0.73 0.80 0.17 
221212 15 0.05 0.98 0.72 0.85 0.33 
112521 10 0.19 0.94 0.71 0.73 0.21 
124314 10 0.06 0.99 0.70 0.94 0.35 
541432 13 0.10 1.00 0.69 0.75 0.29 
323333 9 0.05 0.98 0.68 0.76 0.32 
443215 12 -0.06 1.00 0.67 0.81 0.35 
342353 10 0.29 0.98 0.66 0.79 0.23 
222121 11 0.05 1.00 0.65 0.75 0.34 
345122 15 0.29 1.00 0.64 0.67 0.25 
214535 12 0.00 0.99 0.63 0.78 0.37 
413511 15 -0.24 0.99 0.62 0.75 0.39 
523634 12 0.05 0.99 0.61 0.57 0.33 
321455 10 0.10 0.99 0.60 0.65 0.33 
424421 16 0.05 0.98 0.59 0.64 0.30 
334254 13 -0.66 0.98 0.58 0.80 0.46 
423433 10 -0.15 1.00 0.58 0.60 0.36 
134322 17 0.10 1.00 0.57 0.59 0.27 
315515 16 0.19 0.97 0.56 0.55 0.25 
545122 13 0.10 0.98 0.55 0.61 0.31 
432623 14 0.07 1.00 0.55 0.56 0.30 
241635 17 -0.09 0.99 0.54 0.57 0.37 
312552 14 0.10 0.95 0.53 0.64 0.35 
344145 11 -0.57 0.98 0.51 0.63 0.48 
412152 11 0.10 0.93 0.50 0.59 0.29 
323443 12 -0.66 1.00 0.49 0.61 0.45 
432255 12 0.00 1.00 0.48 0.48 0.42 
325455 14 -0.19 0.91 0.47 0.54 0.36 
431623 15 -0.88 0.99 0.45 0.67 0.47 
423343 15 0.00 1.00 0.44 0.38 0.31 
544352 11 -0.57 0.98 0.43 0.47 0.48 
131542 19 -0.66 0.96 0.42 0.45 0.41 
323644 10 0.10 0.99 0.40 0.29 0.31 
141653 12 0.00 0.91 0.39 0.36 0.34 
434654 16 -0.85 1.00 0.38 0.55 0.61 
534644 11 -0.28 0.98 0.35 0.32 0.32 
535645 8 -0.56 0.76 0.10 0.10 0.39 
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TABLE 5: Models with main effects 
  
  Constant forced to unity 
 (1) (2) (3) (4) (5) (6)
 OLS RE Mean Median RE Mean
c 0.826 0.833 0.827 0.945 1.000 1.000
PF2 -0.009 -0.021 -0.014 -0.011 -0.058 -0.060
PF3 0.008 -0.026 0.008 0.026 -0.051 -0.020
PF4 -0.036 -0.065 -0.027 0.001 -0.088 -0.060
PF5 -0.032 -0.044 -0.043 -0.064 -0.061 -0.063
PF6 -0.115 -0.135 -0.096 -0.097 -0.160 -0.131
RL2 -0.023 -0.027 -0.019 -0.026 -0.056 -0.057
RL3 -0.035 -0.055 -0.043 -0.035 -0.076 -0.068
RL4 -0.034 -0.055 -0.036 -0.026 -0.078 -0.066
SF2 -0.015 -0.034 -0.027 -0.029 -0.066 -0.071
SF3 -0.041 -0.022 -0.049 -0.079 -0.048 -0.084
SF4 -0.047 -0.041 -0.057 -0.053 -0.066 -0.093
SF5 -0.085 -0.089 -0.073 -0.113 -0.109 -0.105
PAIN2 0.011 -0.001 0.008 0.003 -0.042 -0.048
PAIN3 0.006 -0.018 -0.001 0.002 -0.046 -0.034
PAIN4 -0.034 -0.026 -0.032 -0.018 -0.055 -0.070
PAIN5 -0.065 -0.068 -0.062 -0.102 -0.103 -0.107
PAIN6 -0.159 -0.155 -0.149 -0.191 -0.178 -0.181
MH2 -0.033 -0.019 -0.026 -0.058 -0.043 -0.057
MH3 -0.025 -0.032 -0.022 -0.043 -0.055 -0.051
MH4 -0.098 -0.093 -0.095 -0.133 -0.115 -0.121
MH5 -0.131 -0.106 -0.114 -0.165 -0.125 -0.140
VIT2 -0.043 -0.006 -0.044 -0.051 -0.040 -0.094
VIT3 -0.036 -0.008 -0.037 -0.034 -0.030 -0.069
VIT4 -0.033 -0.011 -0.029 -0.048 -0.040 -0.069
VIT5 -0.077 -0.068 -0.076 -0.090 -0.087 -0.106
N 3518 3518 249 249 3518 249
adj R2 0.204 0.200 0.583 0.577 # 0.508
inconsistencies 2 2 2 3 4 5
MAE 0.072 0.073 0.071 0.097 0.078 0.074
No > |0.05| 120 122 117 136 122 118
No > |0.10| 49 53 52 78 59 52
t(mean=0) 0.544 0.250 † † -6.717 †
JBPRED 0.376 1.178 0.737 1.725 2.461 0.681
LB 333.01 386.63 520.71 560.88 185.3 169.57
All models are estimated with White's heteroscedasticity consistent standard errors. 
Estimates shown in bold are significant at t0.10 
# no R
2
 statistics (GEE estimation)  
† Mean error is zero by definition.  
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TABLE 6:  Models with interaction effects  
 
  Constant forced to unity 
 (7) (8) (9) (10)
 RE Mean RE mean
c 0.799 0.788 1.000 1.000
PF2 -0.023 -0.015 -0.050 -0.053
PF3 -0.021 0.011 -0.038 -0.011
PF4 -0.054 -0.018 -0.069 -0.040
PF5 -0.035 -0.034 -0.046 -0.054
PF6 -0.119 -0.084 -0.145 -0.111
RL2 -0.030 -0.021 -0.051 -0.053
RL3 -0.042 -0.030 -0.058 -0.055
RL4 -0.041 -0.024 -0.063 -0.050
SF2 -0.030 -0.023 -0.054 -0.055
SF3 -0.012 -0.040 -0.032 -0.067
SF4 -0.025 -0.042 -0.044 -0.070
SF5 -0.071 -0.058 -0.096 -0.087
PAIN2 -0.005 0.005 -0.037 -0.047
PAIN3 -0.013 0.004 -0.034 -0.025
PAIN4 -0.020 -0.025 -0.040 -0.056
PAIN5 -0.055 -0.049 -0.081 -0.091
PAIN6 -0.141 -0.136 -0.167 -0.167
MH2 -0.022 -0.030 -0.036 -0.049
MH3 -0.028 -0.019 -0.045 -0.042
MH4 -0.085 -0.089 -0.099 -0.109
MH5 -0.098 -0.109 -0.115 -0.128
VIT2 -0.006 -0.044 -0.032 -0.086
VIT3 -0.002 -0.031 -0.019 -0.061
VIT4 -0.001 -0.019 -0.022 -0.054
VIT5 -0.054 -0.064 -0.073 -0.091
Most -0.052 -0.041 -0.084 -0.070
Least 0.049 0.048 
  
n 3518 249 3518 249
adj R2 0.201 0.591 # 0.526
inconsistencies 2 1 6 5
MAE 0.073 0.070 0.076 0.073
No > |0.05| 121 115 119 120
No > |0.10| 57 52 59 51
t(mean=0) 0.293 † -5.110 -1.146
JBPRED 1.336 1.017 1.038 0.173
LB 388.30 524.64 164.18 189.87
All models are estimated with White's heteroscedasticity consistent standard errors. 
Estimates shown in bold are significant at t0.10 
# no R
2
 statistics (GEE estimation)  
† Mean error is zero by definition.  
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